If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
51.00    1.00 (2.00%)
Bid:
50.00
Ask:
52.00
Spread: 2.00 (4.00%)
Market Cap: £97.85m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Market update

11 Apr 2016 07:00

RNS Number : 7163U
Iofina PLC
11 April 2016
 

 

11 April 2016

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Q1 MARKET UPDATE

124.6 metric tonnes of iodine produced from five IOsorb® plants

Production target of 250-270 metric tonnes of iodine in H1 2016

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today provides an update to the market regarding iodine production in the first quarter of 2016.

 

Iofina produced a total of 124.6 metric tonnes (''MT'') of crystalline iodine in Q1 2016 from its five IOsorb® plants. This compares to 127.9MT of crystalline iodine produced from six plants in Q1 2015 of which over 5.5MT was produced at the now closed IOsorb® IO#1 plant. The net iodine production in Q1 from the Company's Oklahoma operations increased year on year. The Board reaffirms its production target of 250-270MT of crystalline iodine in H1 2016.

 

Historically, Iofina's iodine production during the winter months is generally more challenging due to downtime driven by temperature and weather related issues. Additionally, and since the Company's 18 January 2016 RNS, the Oklahoma Corporation Commission (''OCC'') has implemented additional plans to reduce produced brine volumes injected into the Arbuckle geologic formation in response to seismic activity in an approximately 10000 sq. mile area of North West and central Oklahoma.

 

The Board is pleased to report that Iofina and its partners have been working cooperatively to ensure that the Company's IOsorb® plants, at a minimum, maintain current levels of brine processing and ideally expand volumes to some of our plants. These plans can vary per IOsorb® plant, but generally entail being less associated with a particular Salt Water Disposal injection well (''SWD''), and more so being tied into the producer's main brine pipeline network. The tie in work is anticipated to commence shortly at two of the Company's IOsorb® plants and should require minimal capital expenditure. Even with the OCC restrictions and a slowdown of new well drilling rates in Iofina's core area, there remains an abundance of brine for the Company's current plants and potential future sites. The Company has continued to implement strategies to trim iodine production costs.

 

In Q1 2016, iodine pricing for large volume users of iodine slipped below US$25/kg. Whilst not definitive, the Board has seen recent signs of price stabilisation across the global iodine market. Some indicators to this price indication are supply/demand equilibrium for iodine in conjunction with the recent weakening of the US Dollar versus the Japanese Yen and Chilean Peso. The Company sees less downside risk for iodine prices in the near term.

 

During Q1, Iofina had a hearing with respect to the Company's requested judicial review of the Atlantis Water Solution's water permit. The Company expects to receive a ruling late in Q2 of 2016 for this non-core project.

 

 

 

 

 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

 

"I am pleased by our response to the challenges faced in 2016. Iofina produced more iodine from its Oklahoma operations at a significantly lower cost than the same period in 2015 and is on target to reach H1 production goals. 

 

"The actions the Board is taking, in conjunction with the Company's producing partners, to mitigate future risk and ensure brine supply remain encouraging. We have been pleased with the continued sales of produced iodine to the global market. The Board continues to actively execute its business plan whilst managing the debt position in the current challenging commodities market. " 

 

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWFASFMSELL
Date   Source Headline
23rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:35 pmRNSPrice Monitoring Extension
22nd Sep 20219:58 amRNSHolding(s) in Company
10th Sep 20214:15 pmRNSHolding(s) in Company
10th Sep 20213:25 pmRNSHolding(s) in Company
15th Jul 20217:00 amRNSH1 2021 Update
18th Jun 20214:36 pmRNSPrice Monitoring Extension
18th Jun 20213:20 pmRNSResult of AGM
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:36 pmRNSPrice Monitoring Extension
27th May 20212:06 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
27th May 202111:06 amRNSSecond Price Monitoring Extn
27th May 202111:00 amRNSPrice Monitoring Extension
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSAnnual Financial Report
21st May 20215:50 pmRNSNotice of Results
15th Apr 20217:00 amRNSQ1 2021 Update
1st Mar 20215:36 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSMarket Update
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Dec 20202:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:00 pmRNSPrice Monitoring Extension
16th Dec 202011:50 amRNSGrant of Share Options
16th Oct 20207:00 amRNSQ3 2020 Update
13th Oct 20204:40 pmRNSSecond Price Monitoring Extn
13th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSINTERIM RESULTS
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:07 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:01 amRNSSecond Price Monitoring Extn
22nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
22nd Sep 20202:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSDebt Refinancing Signed
26th Aug 20207:00 amRNSDebt Update
31st Jul 20208:00 amRNSLaunch of new website
22nd Jul 202011:06 amRNSSecond Price Monitoring Extn
22nd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSCorporate Update
30th Jun 20202:36 pmRNSDebt Update
30th Jun 202011:52 amRNSResult of AGM
26th Jun 20201:26 pmRNSChange of venue for AGM on 30 June 2020
26th Jun 20207:00 amRNSIO#8 and Debt Update
27th May 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.